| Symbol |
Name |
|
ACTN4
|
actinin, alpha 4
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGO1
|
argonaute RISC catalytic component 1
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMER1
|
APC membrane recruitment protein 1
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
|
|
AR
|
androgen receptor
|
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
|
ARL11
|
ADP-ribosylation factor-like 11
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
AXIN2
|
axin 2
|
|
BABAM1
|
BRISC and BRCA1 A complex member 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BCCIP
|
BRCA2 and CDKN1A interacting protein
|
|
BLOC1S3
|
biogenesis of lysosomal organelles complex-1, subunit 3
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD7
|
bromodomain containing 7
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
CASR
|
calcium-sensing receptor
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CD14
|
CD14 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHEK2
|
checkpoint kinase 2
|
|
CLSPN
|
claspin
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CREBBP
|
CREB binding protein
|
|
CTAGE1
|
cutaneous T-cell lymphoma-associated antigen 1
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
DAZL
|
deleted in azoospermia-like
|
|
DEFB4A
|
defensin, beta 4A
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIS3L2
|
DIS3 like 3'-5' exoribonuclease 2
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DND1
|
DND microRNA-mediated repression inhibitor 1
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPPA3
|
developmental pluripotency associated 3
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
E2F3
|
E2F transcription factor 3
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELANE
|
elastase, neutrophil expressed
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHB2
|
EPH receptor B2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ESR1
|
estrogen receptor 1
|
|
ETV6
|
ets variant 6
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FH
|
fumarate hydratase
|
|
FLCN
|
folliculin
|
|
FLVCR2
|
feline leukemia virus subgroup C cellular receptor family, member 2
|
|
FOXP3
|
forkhead box P3
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FZD4
|
frizzled class receptor 4
|
|
GATA2
|
GATA binding protein 2
|
|
GATA4
|
GATA binding protein 4
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HAND1
|
heart and neural crest derivatives expressed 1
|
|
HFM1
|
HFM1, ATP-dependent DNA helicase homolog (S. cerevisiae)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HOXB13
|
homeobox B13
|
|
HPN
|
hepsin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2-AS
|
IGF2 antisense RNA
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IL32
|
interleukin 32
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
INHBA
|
inhibin, beta A
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNQ1OT1
|
KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
|
|
KERA
|
keratocan
|
|
KIF1B
|
kinesin family member 1B
|
|
KIF21A
|
kinesin family member 21A
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLLN
|
killin, p53-regulated DNA replication inhibitor
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT17
|
keratin 17, type I
|
|
L3MBTL1
|
l(3)mbt-like 1 (Drosophila)
|
|
LAMB3
|
laminin, beta 3
|
|
LEMD3
|
LEM domain containing 3
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LHX4
|
LIM homeobox 4
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LUM
|
lumican
|
|
LZTR1
|
leucine-zipper-like transcription regulator 1
|
|
LZTS1
|
leucine zipper, putative tumor suppressor 1
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MADD
|
MAP-kinase activating death domain
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGEA6
|
melanoma antigen family A6
|
|
MALT1
|
MALT1 paracaspase
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAX
|
MYC associated factor X
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR125A
|
microRNA 125a
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MT-TL1
|
tRNA
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC19
|
mucin 19, oligomeric
|
|
MUTYH
|
mutY homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH8
|
myosin, heavy chain 8, skeletal muscle, perinatal
|
|
NBN
|
nibrin
|
|
NCF4
|
neutrophil cytosolic factor 4, 40kDa
|
|
NF1
|
neurofibromin 1
|
|
NKAIN2
|
Na+/K+ transporting ATPase interacting 2
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NLRP7
|
NLR family, pyrin domain containing 7
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPN3
|
opsin 3
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PDCD10
|
programmed cell death 10
|
|
PDE11A
|
phosphodiesterase 11A
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1
|
|
PDK2
|
pyruvate dehydrogenase kinase, isozyme 2
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PIGT
|
phosphatidylinositol glycan anchor biosynthesis, class T
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
POLB
|
polymerase (DNA directed), beta
|
|
POLD1
|
polymerase (DNA directed), delta 1, catalytic subunit
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCSH
|
protein kinase C substrate 80K-H
|
|
PRLR
|
prolactin receptor
|
|
PSEN2
|
presenilin 2
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPRD
|
protein tyrosine phosphatase, receptor type, D
|
|
PTPRG
|
protein tyrosine phosphatase, receptor type, G
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAD51C
|
RAD51 paralog C
|
|
RAD51D
|
RAD51 paralog D
|
|
RAD52
|
RAD52 homolog (S. cerevisiae)
|
|
RAD54L
|
RAD54-like (S. cerevisiae)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RASAL1
|
RAS protein activator like 1 (GAP1 like)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBL1
|
retinoblastoma-like 1
|
|
RET
|
ret proto-oncogene
|
|
RHNO1
|
RAD9-HUS1-RAD1 interacting nuclear orphan 1
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNF31
|
ring finger protein 31
|
|
RP1
|
retinitis pigmentosa 1 (autosomal dominant)
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
SBF2
|
SET binding factor 2
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
|
SDHAF2
|
succinate dehydrogenase complex assembly factor 2
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SEC63
|
SEC63 homolog (S. cerevisiae)
|
|
SFTPA2
|
surfactant protein A2
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SH3BP2
|
SH3-domain binding protein 2
|
|
SHH
|
sonic hedgehog
|
|
SIAE
|
sialic acid acetylesterase
|
|
SIPA1
|
signal-induced proliferation-associated 1
|
|
SLC29A3
|
solute carrier family 29 (equilibrative nucleoside transporter), member 3
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLX4
|
SLX4 structure-specific endonuclease subunit
|
|
SMAD4
|
SMAD family member 4
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SNAI1
|
snail family zinc finger 1
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK11
|
serine/threonine kinase 11
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
|
SULT2B1
|
sulfotransferase family, cytosolic, 2B, member 1
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TMEM127
|
transmembrane protein 127
|
|
TNC
|
tenascin C
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRB
|
T cell receptor beta locus
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSG101
|
tumor susceptibility 101
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TYMS
|
thymidylate synthetase
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIM
|
vimentin
|
|
WNT5B
|
wingless-type MMTV integration site family, member 5B
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
XBP1
|
X-box binding protein 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
